Project Grant K99HL173555
Award Date
8/12/24
Completion Date
7/31/26
Dollars Obligated
$131K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
미국 뉴욕
Similar Awards
This Project Grant award of $324,440 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) will support research to assess the contribution of epigenetics to cardiovascular disease risk in African American women. The primary awardee, the University of North Carolina at Chapel Hill, will collaborate with Stanford University and the Fred Hutchinson Cancer Center to identify epigenetic biomarkers of cardiovascular...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $103,948 to Emory University to evaluate how immigration status contributes to disparities in cardiometabolic health and accelerated epigenetic aging among Hispanic/Latino populations in the United States. The research aims to: 1) Use data from the California Health Interview Survey to assess associations between immigration...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $777,954 to the Icahn School of Medicine at Mount Sinai to conduct a mixed-method study on the impact of school-based policies on adolescent cardiovascular health and maternal morbidity. The study aims to establish a school-based adolescent preconception cohort, engage adolescents and stakeholders to co-design school-based solutions,...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $2,709,341.45 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Trustees of Columbia University in the City of New York. The grant, with a performance period from September 1, 2024 to March 21, 2025, will fund a daily diary study examining the influence of intersectional stigma, including anticipated and vicarious stigma, on blood pressure...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $242,310 to the University of Washington to investigate the impact of epigenetic heterogeneity on hematopoiesis. The project aims to determine the extent of epigenetic heterogeneity present in hematopoietic stem cells (HSCs) and evaluate how this epigenetic state diversity impacts HSC lineage potential. The research will leverage...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) will fund research to investigate the molecular mechanisms by which environmental/lifestyle risk factors influence cardiovascular traits and disease risk. The $121,500 award to the University of Texas MD Anderson Cancer Center will leverage multi-omics data from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program to conduct...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $602,099 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Icahn School of Medicine at Mount Sinai. The grant will fund a 4-year longitudinal study to assess the impact of place-based structural racism during pregnancy on future cardiopulmonary health outcomes among 440 underrepresented minority women in New York City. The research will examine associations between structural racism, mid-pregnancy...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support research to investigate the impact of power outages on cardiovascular health outcomes in New York State. The $108,524 award to The Trustees of Columbia University in the City of New York will be used to (1) examine the association between power outages and cardiovascular disease hospitalizations, (2) determine the effects of...
This $162,000 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research by Northeastern University to understand how individual and sociopolitical factors affect cardiovascular disease (CVD) preventive care utilization among Black and Latinx immigrant adults. The research plan includes three main components: 1) estimating trends and associations between state/county-level...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research (CFDA 93.837) program, provides $732,779 to the University of Arizona to study the role of the serine-threonine kinase SGK1 in cardiometabolic heart failure with preserved ejection fraction (CMET HFPEF). The research aims to determine how cardiac-specific SGK1 regulates heart function, metabolism, and...